IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SALVI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.805
NA - Nord America 4.568
AS - Asia 2.503
SA - Sud America 304
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 12
Totale 12.237
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.485
PL - Polonia 1.390
DE - Germania 1.017
CN - Cina 919
SG - Singapore 685
UA - Ucraina 660
IT - Italia 504
HK - Hong Kong 326
FI - Finlandia 299
BR - Brasile 275
RU - Federazione Russa 228
GB - Regno Unito 209
IN - India 182
FR - Francia 169
TR - Turchia 146
IE - Irlanda 106
SE - Svezia 81
VN - Vietnam 80
CA - Canada 56
ID - Indonesia 48
BE - Belgio 47
AT - Austria 23
MX - Messico 18
NL - Olanda 18
EU - Europa 17
BD - Bangladesh 16
IR - Iran 12
RO - Romania 12
AU - Australia 11
AR - Argentina 10
CZ - Repubblica Ceca 10
KR - Corea 10
PK - Pakistan 8
AZ - Azerbaigian 7
ES - Italia 7
SA - Arabia Saudita 7
TH - Thailandia 7
EC - Ecuador 6
IQ - Iraq 6
MU - Mauritius 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
LY - Libia 5
OM - Oman 5
GR - Grecia 4
IL - Israele 4
JP - Giappone 4
MA - Marocco 4
BG - Bulgaria 3
BO - Bolivia 3
JM - Giamaica 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LT - Lituania 3
UZ - Uzbekistan 3
AL - Albania 2
AM - Armenia 2
CL - Cile 2
CO - Colombia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HU - Ungheria 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
SD - Sudan 2
TN - Tunisia 2
TW - Taiwan 2
VE - Venezuela 2
BB - Barbados 1
CH - Svizzera 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
IM - Isola di Man 1
KG - Kirghizistan 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 12.237
Salva come PNG Salva come JPEG
Città #
Warsaw 1.389
Jacksonville 451
Singapore 450
Fairfield 378
Chandler 361
Hong Kong 320
Woodbridge 311
Ashburn 287
Ann Arbor 276
Beijing 246
Houston 202
Princeton 196
Brescia 185
Helsinki 185
Wilmington 183
Nanjing 167
Cambridge 164
New York 156
Seattle 137
Istanbul 109
Dublin 106
Munich 102
Dearborn 87
Des Moines 80
Los Angeles 72
Dong Ket 70
Chicago 53
Nanchang 53
Shenyang 49
Jinan 46
San Francisco 46
Brussels 45
Changsha 45
Jakarta 45
Moscow 43
Hebei 42
Milan 42
Shanghai 41
Lancaster 39
Pune 35
Tianjin 34
Jiaxing 32
Turku 27
San Diego 25
Kocaeli 24
Kunming 23
The Dalles 23
Salt Lake City 22
São Paulo 21
Toronto 21
Buffalo 19
Nuremberg 18
Nürnberg 18
Lappeenranta 17
North York 17
Santa Clara 17
Hangzhou 16
Ningbo 16
Verona 15
Boardman 13
London 13
Tampa 13
Zhengzhou 13
Brooklyn 12
Phoenix 12
Romola 12
Vienna 12
Mexico City 11
Falkenstein 10
Dallas 9
Frankfurt am Main 9
Taizhou 9
Elk Grove Village 8
Guangzhou 8
Haikou 8
Ho Chi Minh City 8
Ottawa 8
Rio de Janeiro 8
Sundbyberg 8
Amsterdam 7
Augusta 7
Botucatu 7
Lanzhou 7
Magnago 7
Melbourne 7
Norwalk 7
Sterling 7
Baku 6
Bari 6
Brno 6
Dulles 6
Fuzhou 6
Naples 6
Recife 6
Bologna 5
Borås 5
Castelnuovo Bozzente 5
Charlotte 5
Colombo 5
Düsseldorf 5
Totale 8.031
Salva come PNG Salva come JPEG
Nome #
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 329
Cultured human amniocytes express hTERT, which is distributed between nucleus and cytoplasm and is secreted in extracellular vesicles 295
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 289
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 238
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 234
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 233
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 212
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 205
Functional Role of microRNA-23b-3p in Cancer Biology 203
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 193
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 186
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 177
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 172
Biological Function of MicroRNA193a-3p in Health and Disease 164
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 164
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 160
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 155
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 155
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 153
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 148
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 145
microRNAs and human hepatocellular carcinoma 144
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 143
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 137
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 136
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 136
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 131
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 128
BRCA1 and BRCA2 genetic test in high risk patients and families : counselling and management 128
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 127
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 125
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 125
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 120
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 119
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 119
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 116
RT-PCR detection of telomerase in intraductal papillary mucinous tumours (IPMT) of the pancreas: preliminary findings. 115
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 114
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 112
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 110
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 110
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 110
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 107
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 106
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 106
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 105
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 105
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 99
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 99
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 98
Urokinase and c-met are target of miR-23b in human cells. 97
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 97
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 95
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 93
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 93
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 91
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 89
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 87
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 87
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 85
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 85
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 84
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 83
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 83
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 83
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 82
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 82
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 81
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 81
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 80
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 80
DNA methylation variations in familial female and male breast cancer 79
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 78
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 77
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 77
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 76
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 76
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 76
Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings 76
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 73
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 72
Inherited duplication of the pseudoautosomal region Xq28 in a subject with Gilles de la Tourette syndrome and intellectual disability: A case report 72
RNA interference for urokinase gene in human hepatocellular carcinoma 71
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 71
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC 71
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 70
Strategie ablative per il silenziamento genico di c-met nell'epatocarcinoma cellulare umano: tecnologia antisenso ed RNAi. 69
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 69
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 68
Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells. 67
The FN13 peptide inhibits human tumor cells invasion through the modulation of alphavbeta3 integrins organization and the inactivation of ILK pathway 67
Emerging role of Telomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 67
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 66
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 65
Profilo proteomico di cellule umane tumorali epatiche dopo silenziamento genico di urochinasi mediante RNAi 64
Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer 64
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 63
The enrichment of miR-23b-3p, miR-126-3p and GAS5 in extracellular vesicles from breast cancer cells treated with sorafenib inhibited the tumor growth of xenografts in zebrafish model 62
Molecular therapies for hepatocellular carcinoma: silencing of urokinase-type plasminogen activator by antisense and siRNA stable u-PA expression 62
Circulating microRNA-23b-3p and tissue microRNA-193a-3p as promising molecular biomarkers in human hepatocellular carcinoma. 61
Totale 11.487
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.768
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.600 47 177 40 185 62 182 68 194 229 187 124 105
2021/2022847 48 155 47 47 7 30 25 52 48 91 94 203
2022/2023949 132 56 34 84 88 225 13 81 138 7 39 52
2023/20241.050 74 27 111 62 46 231 68 34 173 49 25 150
2024/20252.739 37 50 49 384 216 240 199 74 332 144 663 351
2025/2026119 119 0 0 0 0 0 0 0 0 0 0 0
Totale 12.499